Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

Xiaolin Nan, Tanja M. Tamgüney, Eric A. Collisson, Li Jung Lin, Cameron Pitt, Jacqueline Galeas, Sophia Lewis, Joe Gray, Frank McCormick, Steven Chu

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Rat sarcoma (Ras) GTPases regulate cell proliferation and survival through effector pathways including Raf-MAPK, and are the most frequently mutated genes in human cancer. Although it is well established that Ras activity requires binding to both GTP and the membrane, details of how Ras operates on the cell membrane to activate its effectors remain elusive. Efforts to target mutant Ras in human cancers to therapeutic benefit have also been largely unsuccessful. Here we show that Ras-GTP forms dimers to activate MAPK. We used quantitative photoactivated localization microscopy (PALM) to analyze the nanoscale spatial organization of PAmCherry1-tagged KRas 4B (hereafter referred to KRas) on the cell membrane under various signaling conditions. We found that at endogenous expression levels KRas forms dimers, and KRasG12D, a mutant that constitutively binds GTP, activates MAPK. Overexpression of KRas leads to formation of higher order Ras nanoclusters. Conversely, at lower expression levels, KRasG12D is monomeric and activates MAPK only when artificially dimerized. Moreover, dimerization and signaling of KRas are both dependent on an intact CAAX (C, cysteine; A, aliphatic; X, any amino acid) motif that is also known to mediate membrane localization. These results reveal a new, dimerization-dependent signaling mechanism of Ras, and suggest Ras dimers as a potential therapeutic target in mutant Ras-driven tumors.

Original languageEnglish (US)
Pages (from-to)7996-8001
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume112
Issue number26
DOIs
StatePublished - Jun 30 2015

Fingerprint

Guanosine Triphosphate
Mitogen-Activated Protein Kinases
Sarcoma
Dimerization
Cell Membrane
Neoplasms
Amino Acid Motifs
Spatial Analysis
Membranes
GTP Phosphohydrolases
Cysteine
Microscopy
Cell Survival
Cell Proliferation
Therapeutics

Keywords

  • Cancer
  • MAPK signaling
  • Ras dimer
  • Single molecule imaging
  • Superresolution microscopy

ASJC Scopus subject areas

  • General

Cite this

Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway. / Nan, Xiaolin; Tamgüney, Tanja M.; Collisson, Eric A.; Lin, Li Jung; Pitt, Cameron; Galeas, Jacqueline; Lewis, Sophia; Gray, Joe; McCormick, Frank; Chu, Steven.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 26, 30.06.2015, p. 7996-8001.

Research output: Contribution to journalArticle

Nan, Xiaolin ; Tamgüney, Tanja M. ; Collisson, Eric A. ; Lin, Li Jung ; Pitt, Cameron ; Galeas, Jacqueline ; Lewis, Sophia ; Gray, Joe ; McCormick, Frank ; Chu, Steven. / Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway. In: Proceedings of the National Academy of Sciences of the United States of America. 2015 ; Vol. 112, No. 26. pp. 7996-8001.
@article{2b53960795f743a7b7200416d38dae9e,
title = "Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway",
abstract = "Rat sarcoma (Ras) GTPases regulate cell proliferation and survival through effector pathways including Raf-MAPK, and are the most frequently mutated genes in human cancer. Although it is well established that Ras activity requires binding to both GTP and the membrane, details of how Ras operates on the cell membrane to activate its effectors remain elusive. Efforts to target mutant Ras in human cancers to therapeutic benefit have also been largely unsuccessful. Here we show that Ras-GTP forms dimers to activate MAPK. We used quantitative photoactivated localization microscopy (PALM) to analyze the nanoscale spatial organization of PAmCherry1-tagged KRas 4B (hereafter referred to KRas) on the cell membrane under various signaling conditions. We found that at endogenous expression levels KRas forms dimers, and KRasG12D, a mutant that constitutively binds GTP, activates MAPK. Overexpression of KRas leads to formation of higher order Ras nanoclusters. Conversely, at lower expression levels, KRasG12D is monomeric and activates MAPK only when artificially dimerized. Moreover, dimerization and signaling of KRas are both dependent on an intact CAAX (C, cysteine; A, aliphatic; X, any amino acid) motif that is also known to mediate membrane localization. These results reveal a new, dimerization-dependent signaling mechanism of Ras, and suggest Ras dimers as a potential therapeutic target in mutant Ras-driven tumors.",
keywords = "Cancer, MAPK signaling, Ras dimer, Single molecule imaging, Superresolution microscopy",
author = "Xiaolin Nan and Tamg{\"u}ney, {Tanja M.} and Collisson, {Eric A.} and Lin, {Li Jung} and Cameron Pitt and Jacqueline Galeas and Sophia Lewis and Joe Gray and Frank McCormick and Steven Chu",
year = "2015",
month = "6",
day = "30",
doi = "10.1073/pnas.1509123112",
language = "English (US)",
volume = "112",
pages = "7996--8001",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "26",

}

TY - JOUR

T1 - Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

AU - Nan, Xiaolin

AU - Tamgüney, Tanja M.

AU - Collisson, Eric A.

AU - Lin, Li Jung

AU - Pitt, Cameron

AU - Galeas, Jacqueline

AU - Lewis, Sophia

AU - Gray, Joe

AU - McCormick, Frank

AU - Chu, Steven

PY - 2015/6/30

Y1 - 2015/6/30

N2 - Rat sarcoma (Ras) GTPases regulate cell proliferation and survival through effector pathways including Raf-MAPK, and are the most frequently mutated genes in human cancer. Although it is well established that Ras activity requires binding to both GTP and the membrane, details of how Ras operates on the cell membrane to activate its effectors remain elusive. Efforts to target mutant Ras in human cancers to therapeutic benefit have also been largely unsuccessful. Here we show that Ras-GTP forms dimers to activate MAPK. We used quantitative photoactivated localization microscopy (PALM) to analyze the nanoscale spatial organization of PAmCherry1-tagged KRas 4B (hereafter referred to KRas) on the cell membrane under various signaling conditions. We found that at endogenous expression levels KRas forms dimers, and KRasG12D, a mutant that constitutively binds GTP, activates MAPK. Overexpression of KRas leads to formation of higher order Ras nanoclusters. Conversely, at lower expression levels, KRasG12D is monomeric and activates MAPK only when artificially dimerized. Moreover, dimerization and signaling of KRas are both dependent on an intact CAAX (C, cysteine; A, aliphatic; X, any amino acid) motif that is also known to mediate membrane localization. These results reveal a new, dimerization-dependent signaling mechanism of Ras, and suggest Ras dimers as a potential therapeutic target in mutant Ras-driven tumors.

AB - Rat sarcoma (Ras) GTPases regulate cell proliferation and survival through effector pathways including Raf-MAPK, and are the most frequently mutated genes in human cancer. Although it is well established that Ras activity requires binding to both GTP and the membrane, details of how Ras operates on the cell membrane to activate its effectors remain elusive. Efforts to target mutant Ras in human cancers to therapeutic benefit have also been largely unsuccessful. Here we show that Ras-GTP forms dimers to activate MAPK. We used quantitative photoactivated localization microscopy (PALM) to analyze the nanoscale spatial organization of PAmCherry1-tagged KRas 4B (hereafter referred to KRas) on the cell membrane under various signaling conditions. We found that at endogenous expression levels KRas forms dimers, and KRasG12D, a mutant that constitutively binds GTP, activates MAPK. Overexpression of KRas leads to formation of higher order Ras nanoclusters. Conversely, at lower expression levels, KRasG12D is monomeric and activates MAPK only when artificially dimerized. Moreover, dimerization and signaling of KRas are both dependent on an intact CAAX (C, cysteine; A, aliphatic; X, any amino acid) motif that is also known to mediate membrane localization. These results reveal a new, dimerization-dependent signaling mechanism of Ras, and suggest Ras dimers as a potential therapeutic target in mutant Ras-driven tumors.

KW - Cancer

KW - MAPK signaling

KW - Ras dimer

KW - Single molecule imaging

KW - Superresolution microscopy

UR - http://www.scopus.com/inward/record.url?scp=84937957816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937957816&partnerID=8YFLogxK

U2 - 10.1073/pnas.1509123112

DO - 10.1073/pnas.1509123112

M3 - Article

C2 - 26080442

AN - SCOPUS:84937957816

VL - 112

SP - 7996

EP - 8001

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 26

ER -